Appendix 4D and Half Year Report
| Stock | Nuchev Ltd (NUC.ASX) |
|---|---|
| Release Time | 24 Feb 2026, 4:29 p.m. |
| Price Sensitive | Yes |
Nuchev Ltd Reports H1 2025 Results
- Revenue up 12% to $12.4 million
- Net loss increased 48.2% to $2.3 million
- Continued investment in growth initiatives, marketing, and operational capability
Nuchev Limited reported a 12% increase in revenue to $12.4 million for the half-year ended 31 December 2025, driven by continued sales growth across the company's core product portfolio and the contribution from the Practitioner channel. However, the company recorded a net loss after tax of $2.34 million, up 48.2% from the prior corresponding period, reflecting Nuchev's continued investment in marketing and promotional activity, product development, and operational capability to support growth. Gross profit increased to $5.72 million, but gross margin declined to 46.2% due to sales mix, promotional activity, and the timing of offshore sales. Operating expenses increased, driven by higher staff costs, advertising and marketing spend, and amortisation. The company remains focused on delivering profitable growth through expansion of its core brands, disciplined development of its new product pipeline, and continued diversification across channels and markets. As scale increases, management is focused on improving operating leverage, cost efficiency, and working capital discipline to support sustainable earnings over time, while maintaining targeted investment in brand, capability, and infrastructure.
The company continues to execute its strategy and progress toward sustainable profitability, supported by the ongoing support of its shareholders.